首页 > 市场调查报告书 > 食物/饮料

机能性食品益生菌

市场调查报告书

商品编码

1741525

医用益生菌市场（按成分类型、分销管道和地区）

Medical Probiotics Market, By Ingredient Type, By Distribution Channel, By Geography

出版日期: 2025年03月27日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计 2025 年医用益生菌市场价值将达到 457.6 亿美元，到 2032 年将达到 701.8 亿美元，2025 年至 2032 年的复合年增长率为 6.3%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	457.6亿美元
效能数据	从2020年到2024年	预测期	2025年至2032年
预测期：2025-2032年复合年增长率：	6.30%	2032年价值预测	701.8亿美元

近年来，医用益生菌因其潜在的健康益处而备受关注。益生菌是对人体，尤其是消化器官系统有益的活菌和酵母。它们天然存在于优格和酸菜等发酵食品中。而医用益生菌则经过特殊配製，旨在提供针对性的健康益处。

全球医用益生菌市场正在快速成长，这得益于人们日益重视肠道健康、慢性病盛行率上升以及对天然和预防性保健解决方案的需求不断增长等因素。医用益生菌以促进消化和增强免疫系统而闻名，使其成为传统药物的极具吸引力的替代品。

市场动态：

预计医用益生菌市场在预测期内将显着成长。该市场的主要驱动因素包括消费者对天然和预防性保健产品的需求不断增长、慢性病盛行率不断上升，以及人们对肠道健康与整体健康之间联繫的理解日益加深。

然而，也存在一些阻碍市场成长的因素。主要挑战之一是缺乏关于医用益生菌使用和标籤的标准化法规，这导致消费者和医疗保健专业人员对这些产品的功效和安全性缺乏信心。此外，医用益生菌价格高昂，在某些地区供应有限，也可能阻碍市场成长。

儘管面临这些挑战，医用益生菌市场仍存在着许多成长机会。益生菌相关研发活动的不断增加、益生菌产品生产和行销技术的进步以及医用益生菌应用领域的不断拓展，都是推动市场成长的一些因素。

本研究的主要特点

本报告对全球医用益生菌市场进行了详细分析，包括预测期（2025-2032 年）的市场规模和年复合成长率（CAGR%），以 2024 年为基准年。
它揭示了各个领域的潜在商机，并说明了该市场的引人注目的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
全球医用益生菌市场报告迎合了该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
相关人员将透过用于分析全球医用益生菌市场的各种策略矩阵更轻鬆地做出决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 45.76 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.30%	2032 Value Projection:	USD 70.18 Bn

Medical probiotics have gained significant attention in recent years due to their potential health benefits. Probiotics are live bacteria and yeasts that are beneficial for the human body, especially the digestive system. They are found naturally in foods like yogurt, sauerkraut, and other fermented products. Medical probiotics, on the other hand, are specifically formulated to provide targeted health benefits.

The global medical probiotics market is growing rapidly, driven by factors such as the increasing awareness about the importance of gut health, rising prevalence of chronic diseases, and the growing demand for natural and preventive healthcare solutions. Medical probiotics are known to support digestion and boost the immune system, making them an attractive alternative to traditional medicines.

Market Dynamics:

The medical probiotics market is expected to witness significant growth during the forecast period. The key drivers of this market include the increasing consumer demand for natural and preventive healthcare options, the rising incidence of chronic diseases, and the growing understanding of the link between gut health and overall well-being.

However, there are also certain restraints that may hinder the market growth. One of the major challenges is the lack of standardized regulations governing the use and labeling of medical probiotics. This leads to a lack of confidence among consumers and healthcare professionals regarding the efficacy and safety of these products. Additionally, the high cost of medical probiotics and the limited availability of products in certain regions may also impede market growth.

Despite these challenges, the medical probiotics market presents several opportunities for growth. The increasing research and development activities related to probiotics, advancements in technology for the production and delivery of probiotic products, and the expanding application areas of medical probiotics are some of the factors driving market growth.

Key Features of the Study:

This report provides in-depth analysis of the global medical probiotics market, including market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
Key companies covered as a part of this study include Probi AB, Chr. Hansen Holding A/S, Danone S.A., Yakult Honsha Co., Ltd., Nestle S.A., DowDuPont Inc., Kerry Group plc, BioGaia AB, Probiotics International Limited (Protexin), and UAS Laboratories LLC.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global medical probiotics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global medical probiotics market.

Medical Probiotics Market Segmentation:

By Ingredient Type
- Bacteria
- Lactobacilli
- Bifidobacterium
- Streptococcus
- Bacillus
- Yeast
- Spore Formers
- Others
By Application
- Probiotic Food & Beverages
- Dairy Products
- Non-dairy Beverages
- Cereals
- Baked Goods
- Fermented Meat Products
- Probiotic Dietary Supplements
- Animal Feed Probiotics
- Probiotics for Women's Health
- Infant Formula
- Others
By End user
- Human Probiotics
- Animal Probiotics
By Distribution Channel
- Hypermarkets/Supermarkets
- Pharmacies/Drugstores
- Specialty Stores
- Online Sales
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Company Profiles
- Probi AB
- Hansen Holding A/S
- Danone S.A.
- Yakult Honsha Co., Ltd.
- Nestle S.A.
- DowDuPont Inc.
- Kerry Group plc
- BioGaia AB
- Probiotics International Limited (Protexin)
- UAS Laboratories LLC

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Ingredient Type
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing product launches for women's health
- Restraints
High R&D costs and stringent regulations
- Opportunities
Facility expansion
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions, and Collaborations

4. Medical Probiotics Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Medical Probiotics Market, By Ingredient Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Bacteria
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Lactobacilli
Bifidobacterium
Streptococcus
Bacillus
Yeast
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Spore Formers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Medical Probiotics Market, By Application, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Probiotic Food & Beverages
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Dairy Products
Non-dairy Beverages
Cereals
Baked Goods
Fermented Meat Products
Probiotic Dietary Supplements
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Probiotics for Women's Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Infant Formula
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Medical Probiotics Market, By Distribution Channel, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Hypermarkets/Supermarkets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Pharmacies/Drugstores
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mon)
Specialty Stores
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Online Sales
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Medical Probiotics Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Sub-region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Sub-region, 2021-2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Ingredient Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Ingredient Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Germany
  - U.K.
  - Spain
  - Russia
  - Italy
  - France
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Ingredient Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - China
  - India
  - Japan
  - South Korea
  - Australia
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Ingredient Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Argentina
  - Brazil
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Ingredient Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020-2032,(US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Ingredient Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Company Profile
- Probi AB
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Abbott
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Lonza
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Hansen Holding A/S
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Danone S.A.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Yakult Honsha Co., Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Nestle S.A.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- DowDuPont Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Kerry Group plc
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- BioGaia AB
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- DSM
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Sun Genomics
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Evonik
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Probiotics International Limited (Protexin)
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- UAS Laboratories LLC
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analysts' Views

10. Section

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

医用益生菌市场（按成分类型、分销管道和地区）